Are Gene Editing Interventions Going to Have a Clinical Impact?

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Gene editing interventions could have a clinical impact over the next 10 years, says Dr Hannah. But we already have some effective gene therapies that haven't made it to patients who need it most, she adds. "We really need to address these problems now if we're going to be able to implement these gene editing precision medicines in a few years' time"

Ian Sample speaks to Guardian science correspondent Hannah Devlin about the latest developments and debates about gene editing to emerge from a summit at the Francis Crick Institute in London. The summit heard from the first person with sickle cell disease to be treated with a technique known as Crispr. He also hears from Prof Claire Booth about ensuring these cutting edge treatments are made available to everyone who needs them. Help support our independent journalism at theguardian.com/sciencepod